Penn Medicine The Mark E. Josephson Thirty-Third Annual State-of-the -Art Arrhythmia Symposium 2026
+ Target Audience: Electrophysiologists, cardiac electrophysiologists, pediatric electrophysiologists, cardiologists, interventional cardiologists, heart failure specialists, medical geneticists, internal medicine physicians, cardiac electrophysiology fellows, EP laboratory staff, nurses, advanced practice providers, and healthcare professionals involved in the diagnosis and treatment of cardiac rhythm disorders.
+ Information:
- Course Title: The Mark E. Josephson Thirty-Third Annual State-of-the-Art Arrhythmia Symposium
- Organizer: Penn Medicine – University of Pennsylvania Health System
- Course Director: Francis E. Marchlinski, MD
- Edition: 33rd Annual Symposium
- Year: 2026
- Primary Specialty: Cardiology and Cardiac Electrophysiology
- Additional Focus: Cardiac Arrhythmias, Catheter Ablation, Cardiac Devices, ECG Interpretation, and Sudden Cardiac Death Prevention
- Educational Approach: Case Presentations, Audience Participation, Didactic Lectures, Q&A Sessions, and Specialty Breakout Sessions
- Faculty: University of Pennsylvania Health System Electrophysiology Faculty and Invited National Experts
+ Description:
The Penn Medicine Mark E. Josephson Thirty-Third Annual State-of-the-Art Arrhythmia Symposium 2026 is an advanced cardiovascular medical education program dedicated to contemporary cardiac electrophysiology, arrhythmia diagnosis, catheter ablation techniques, cardiac rhythm management devices, and sudden cardiac death prevention.
Directed by Francis E. Marchlinski, MD, the symposium brings together electrophysiologists, cardiologists, heart failure specialists, and other healthcare professionals to review important developments in invasive and non-invasive electrophysiologic and electrocardiographic evaluation.
The educational program examines atrial fibrillation, atrial flutter, premature ventricular contractions (PVCs), nonsustained ventricular tachycardia (NSVT), genetically linked arrhythmia syndromes, stroke prevention, left atrial appendage occlusion, advanced cardiac devices, and emerging electrophysiology technologies.
Additional emphasis is placed on artificial intelligence in electrophysiology, genetic testing, ambulatory rhythm monitoring, catheter ablation innovations, leadless pacing, defibrillating devices, conduction system pacing, cardiac contractility modulation, and optimized outpatient procedural care.
The symposium combines expert-led lectures, case-based presentations, interactive discussions, and specialized breakout sessions to support evidence-based decision-making and advanced arrhythmia management.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the appropriate evaluation of patients with frequent PVCs and NSVT as well as indications for treatment including ablation and antiarrhythmic medications.
- Recognize ECG clues to detect patients at risk for serious arrhythmias and sudden death.
- Apply into practice the newest information regarding evaluation and treatment of atrial arrhythmias including screening for episodes and ablation indications, techniques, and endpoints.
- Describe the indications for “leadless” pacing and defibrillating devices and optimum implantation techniques.
- Review the indications, contraindications, and complications associated with left atrial (LA) appendage occlusion and closure.
- Discuss the methods, techniques, associated tools, and equipment including emerging technologies to perform catheter ablation of atrial fibrillation and flutter.
- Recognize use and value of new techniques and technologies employed for complex EP devices and ablation cases.
- Apply into practice the ECG patterns/clinical characteristics, evaluation, and treatment of patients with genetically linked arrhythmia syndromes.
- Identify the importance of genetic testing and implications regarding results in the treatment of patients with arrhythmias.
- Review the role of AI in electrophysiology including role in ECG interpretation for VT/SCD risk, ambulatory monitoring, and pre-procedure imaging.
- Employ the latest advances in device therapy for the treatment of patients with heart failure including cardiac contractility modulation and conduction system pacing.
- Recognize the use and value of ambulatory monitoring for screening/treating arrhythmias and assessing clinical status.
- Define the importance of risk factor modification in the treatment of atrial fibrillation and how to achieve goals including the use of GLP1 agonists, effective treatment of high blood pressure and obstructive sleep apnea.
- Describe appropriate use of anticoagulation for stroke prevention in patients with atrial fibrillation including implications of recent trial data and potential new medications.
- Interpret how to choose the right patients, use appropriate access and closure techniques, as well as review the tools needed to facilitate same day discharge following ablation and other invasive EP procedures.
Comprehensive Topics Covered
1. Premature Ventricular Contractions (PVCs) and Nonsustained Ventricular Tachycardia (NSVT)
Evaluation of frequent PVCs and NSVT, clinical risk assessment, indications for treatment, antiarrhythmic medication considerations, and catheter ablation strategies.
2. Electrocardiographic Risk Assessment and Sudden Cardiac Death
Review of ECG patterns and clinical findings associated with potentially serious cardiac arrhythmias, ventricular tachycardia, and sudden cardiac death risk.
3. Atrial Fibrillation and Atrial Flutter Management
Contemporary evaluation and management of atrial arrhythmias, including rhythm screening, treatment selection, ablation indications, procedural techniques, and clinical endpoints.
4. Catheter Ablation Technologies and Techniques
Discussion of methods, equipment, emerging technologies, and procedural strategies used in catheter ablation for atrial fibrillation, atrial flutter, and complex cardiac arrhythmias.
5. Leadless Pacing and Defibrillating Devices
Clinical indications, device selection, implantation considerations, and advances in leadless cardiac pacing and defibrillation technologies.
6. Left Atrial Appendage Occlusion and Closure
Review of patient selection, indications, contraindications, potential complications, and clinical considerations associated with left atrial appendage occlusion procedures.
7. Complex Electrophysiology Procedures
Emerging technologies and techniques supporting challenging electrophysiology device procedures and advanced catheter ablation cases.
8. Inherited and Genetically Linked Arrhythmia Syndromes
Recognition of characteristic ECG patterns, clinical presentations, diagnostic evaluation, and treatment considerations for genetically associated cardiac rhythm disorders.
9. Genetic Testing in Cardiac Electrophysiology
Clinical applications of genetic testing, interpretation of results, implications for patient management, and the role of genetic information in arrhythmia evaluation.
10. Artificial Intelligence in Electrophysiology
Applications of AI-assisted ECG interpretation, ventricular tachycardia and sudden cardiac death risk assessment, ambulatory rhythm monitoring, and pre-procedural cardiac imaging.
11. Heart Failure and Advanced Cardiac Device Therapy
Review of cardiac contractility modulation, conduction system pacing, and emerging device-based therapies for selected patients with heart failure.
12. Ambulatory Cardiac Rhythm Monitoring
Use of ambulatory monitoring technologies to detect cardiac arrhythmias, guide treatment decisions, evaluate clinical status, and assess therapeutic outcomes.
13. Atrial Fibrillation Risk Factor Modification
Management of modifiable atrial fibrillation risk factors, including obesity, hypertension, and obstructive sleep apnea, alongside the potential role of GLP-1 receptor agonists in appropriate patients.
14. Anticoagulation and Stroke Prevention
Evidence-based anticoagulation strategies in atrial fibrillation, clinical implications of recent trial findings, emerging antithrombotic treatments, and individualized stroke prevention.
15. Electrophysiology Procedure Optimization and Same-Day Discharge
Patient selection, vascular access techniques, closure strategies, procedural workflow, and tools supporting safe same-day discharge following catheter ablation and other invasive electrophysiology procedures.
Keynote Lectures and Featured Faculty
Leonard N. Horowitz, MD Memorial Lecture
Featured Speaker: Pasquale Santangeli, MD, PhD
Professor of Medicine, Associate Section Head, and Director of the Ventricular Tachycardia (VT) Program, Cleveland Clinic, Cleveland, Ohio.
Mark E. Josephson, MD Lecture
Featured Speaker: David Callans, MD
Professor of Medicine and Co-Director of Electrophysiology, Penn Medicine, Philadelphia, Pennsylvania.
Course Director
Francis E. Marchlinski, MD
Course Director of the Thirty-Third Annual State-of-the-Art Arrhythmia Symposium.
The educational program features faculty and staff from the University of Pennsylvania Health System, Department of Electrophysiology, together with invited speakers from other institutions.
Educational Format and Breakout Sessions
The symposium combines:
- Expert-led didactic presentations
- Clinical case presentations
- Audience participation and interactive discussions
- Question-and-answer sessions
- Multidisciplinary arrhythmia management discussions
- Advanced electrophysiology education
Morning Educational Sessions
Lectures designed for the full audience, emphasizing contemporary arrhythmia diagnosis, electrophysiologic evaluation, and treatment strategies.
Afternoon Breakout Sessions
The original program includes three specialized breakout sessions:
1. Associated Professionals Session
Designed for nurses, advanced practice providers, and other healthcare professionals involved in electrophysiology and arrhythmia care.
2. General Cardiology Session
Designed for general cardiologists and clinicians managing patients with cardiac rhythm disorders.
3. Advanced Electrophysiology Session
Designed for electrophysiology fellows, practicing electrophysiologists, and electrophysiology laboratory staff.
Educational Highlights
- Advanced cardiac electrophysiology and arrhythmia management
- Premature ventricular contractions and nonsustained ventricular tachycardia
- ECG interpretation and sudden cardiac death risk assessment
- Atrial fibrillation and atrial flutter treatment
- Advanced catheter ablation techniques
- Leadless cardiac pacing and defibrillating devices
- Left atrial appendage occlusion and closure
- Inherited arrhythmia syndromes and genetic testing
- Artificial intelligence in electrophysiology
- Ambulatory cardiac rhythm monitoring
- Cardiac contractility modulation and conduction system pacing
- Heart failure device therapy
- Atrial fibrillation risk factor modification
- Anticoagulation and stroke prevention
- Same-day discharge after electrophysiology procedures
- Case-based discussions and specialty breakout sessions
Clinical & Educational Value
The Penn Medicine Mark E. Josephson Thirty-Third Annual State-of-the-Art Arrhythmia Symposium 2026 provides advanced education in the diagnosis, evaluation, and treatment of cardiac rhythm disorders.
The symposium integrates invasive and non-invasive electrophysiology, electrocardiographic assessment, catheter ablation, cardiac devices, genetic testing, emerging technologies, and evidence-based management strategies.
Its multidisciplinary educational approach supports clinical decision-making for electrophysiologists, cardiologists, heart failure specialists, and other professionals involved in cardiovascular care.
The program also emphasizes collaboration between electrophysiology specialists, general cardiologists, advanced practice providers, and electrophysiology laboratory teams.
Important Access Information
This description summarizes the original Penn Medicine educational symposium. The topics listed above represent its stated educational scope and learning objectives rather than a verified session-by-session lecture inventory.
The number, format, and completeness of recordings or supporting educational files included in any separately purchased digital package should be confirmed before purchase.
Official Penn Medicine conference registration, live participation, faculty interaction, access to the organizer’s learning platform, CME credits, and certificates are not included unless expressly stated in the purchased package.
Short Description
The Penn Medicine Mark E. Josephson Thirty-Third Annual State-of-the-Art Arrhythmia Symposium 2026 provides advanced cardiac electrophysiology education covering atrial fibrillation, ventricular arrhythmias, catheter ablation, leadless pacing, cardiac devices, left atrial appendage occlusion, genetic testing, AI-assisted ECG interpretation, stroke prevention, and heart failure device therapies.
Topics
- AI in Electrophysiology – Ready for Primetime
- Cardiac Contractility Modulation Therapy for Heart Failure
- Changing Concepts in Post-MI Ventricular Tachycardia
- Common Congenital Heart Disease in Adults and Associated Arrhythmias- Pediatric EP Perspective
- Conduction System Pacing
- Creating an Atrial Fibrillation Center of Excellence – Addressing the Remaining Challenges and Filling Knowledge-Technology Gaps
- Debate- Ablation of VT Should be Performed Coincident with ICD Implant
- Epicardial Mapping and VT Ablation in Patients with an Ischemic Substrate
- Extravascular ICD Therapy- Highlights of Implantation Techniques in the EP Lab-Prerecorded Case(s)
- Extravascular ICD Therapy-Case Based Illustrations
- Highlights from New Guidelines on Antiarrhythmic Drug Use for Atrial Fibrillation in Understudied Situations
- How Does Radioablation Work– Lessons Learned From the Translational Laboratory
- How I Approach the Diagnosis of SVT Mechanism- 7 Tips to Remember
- How to Recognize and Ablate Septal VT Substrate Circuits in NICM
- How to Target the Most Complex VT Substrates – A Labor of Love
- Identifying High Risk of Arrhythmia Event Before the Life-Threatening Episode in Nonischemic Syndromes
- Inherited Arrhythmia and Cardiomyopathy Syndromes
- Leadless AV Pacing
- Lessons Learned from Serial MR Imaging in VT Ablation Patients
- New Access and Closure Techniques and Technology
- New Insights on Ablation Lesion Formation
- New Strategies for Mapping and Ablating VT Substrate
- New Trends in Atrial Fibrillation Risk Factor Modification
- Nonsustained VT- When to Worry
- Non-Thermal Pulsed Field Energy for Atrial Fibrillation Ablation
- Panel Discussion with ARS- Atrial Fibrillation Management Controversies – Have Large Trials Provided a Roadmap for Therapy
- ParaHisian VT and VPD ablation- Tips and Tricks to Optimize Safety and Efficacy
- Preparing Your Patient to Get Safely Into and Out of the EP Lab
- Rapid Fire Cases- New Technology Updates- PFA, Leadless and Extravascular Leads-Devices, Cardioneuroablation, LAAO Panel Discu…
- Role of Genetic Testing in EP Decision Making
- Same Day Discharge – Devices, AF Ablation, LAAO
- Sarcoidosis- Diagnosis, Treatment, Identification of VT Risk and Role-Timing of Ablation
- Troubleshooting Devices and Monitors
- Update on Cardioneuroablation
- Welcome and Introductions
- What to Do with Low Burden Atrial Fibrillation
- What’s New in Medical Prevention of Strokes




